A follow-up study on men tested for BRCA1/BRCA2 mutations: Impacts and coping processes

Psycho-Oncology

Volumn 22, Issue 2, 2013, Pages 417-425

  Shiloh, Shoshana ^a   Dagan, Efrat ^b   Friedman, Irit ^c   Blank, Natalie ^a,c   Friedman, Eitan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

BRCA mutations; breast cancer; coping; genetics; men; oncology

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; EMOTION; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH BEHAVIOR; HUMAN; MALE; OVARY CANCER; PERCEPTION; QUESTIONNAIRE; TELECONSULTATION; TUMOR SUPPRESSOR GENE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; BREAST NEOPLASMS, MALE; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH BEHAVIOR; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; PERCEPTION;

EID: 84873410525     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2106     Document Type: Article

References (65)

1. Agrawal A, Ayantunde AA, Rampaul R, Robertson JFR,. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007; 103: 11-21.
2. Benyamini Y,. Stress and coping with women's health issues: a review from a self-regulation perspective. European Psychologist 2009; 14: 63-71.
3. Blandy C, Chabal F, Stoppa-Lyonnet D, et al,. Testing participation in BRCA1/2-positive families: initiator role of index cases. Genet Test 2003; 7: 225-233.
4. Broadbent E, Petrie KJ, Main J, et al,. The brief illness perception questionnaire. J Psychosom Res 2006; 60: 631-637.
5. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL,. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002; 94: 1365-1372.
6. Cella D, Hughes C, Peterman A, et al,. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 2002; 21: 564-572.
7. Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J,. Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. Eur J Med Genet 2008; 51: 141-147.
8. d'Agincourt-Canning L,. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001; 15: 231-247.
9. d'Agincourt-Canning L, Baird P,. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol 2006; 58: 114-123.
10. Daly MB,. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns 2009; 18: 42-48.
11. Daly PA, Nolan C, Green A, et al,. Predictive testing for BRCA1 and 2 mutations: a male contribution. Annuals of Oncology 2003; 14: 549-553.
12. Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, Denayer L, Claes E,. Cognitive representations of breast cancer, emotional distress and preventive health behavior: a theoretical perspective. Psycho-Oncology 2000; 9: 528-536.
13. Dudok De Wit AC, Tibben A, Frets PG, NMeijers-Heijboer EJ, Devilee P, Niermeijer MF,. Males at-risk for the BRCA1-gene, the psychological impact. Psycho-Oncology 1996; 5: 251-257.
14. Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F,. Risk of breast cancer in male BRCA2 carriers. J Med Genet 2010; 47: 710-711.
15. Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, et al,. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 2008; 12: 81-91.
16. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN,. Breast carcinoma in men: a population-based study. Cancer 2004; 101: 51-57.
17. Graves KD, Wenzel L, Schwartz MD, et al,. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010; 19: 648-654.
18. Hallowell N, Ardern-Jones A, Eeles R, et al,. Men's decision-making about predictive BRCA1/2 testing: the role of family. J Genet Couns 2005a; 14: 207-217.
19. Hallowell N, Ardern-Jones A, Eeles R, et al,. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 2005b; 67: 492-502.
20. Hallowell N, Arden-Jones A, Eeles R, et al,. Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/ 2 mutations within their family. Sociol Health Illn 2006; 28: 969-988.
21. Heshka JT, Palleschi C, Howley H, et al,. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008; 10: 19-32.
22. Jemal A, Siegel R, Xu J, Wardm E,. Cancer statistics, 2010. CA-A Cancer Journal for Clinicians 2010; 60: 277-300.
23. Juan AS, Wakefield CE, Kasparian NA, et al,. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2). Genet Test 2008; 12: 523-532.
24. Katapodi MC, Aouizerat BE,. Do women in the community recognize hereditary and sporadic breast cancer risk factors? Oncol Nurs Forum 2005; 32: 617-623.
25. Kelly K, Leventhal, H, Andrykowski, M, et al,. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-Oncology 2005; 14: 34-48.
26. Kessler S, Resta RG,. Psyche and Helix Psychological Aspects of Genetic Counseling. Wiley-Liss: New York, 2000.
27. Kirchhoff T, Kauff N, Kolachana P, et al,. BRCA mutations and the risk of prostate and colorectal cancer in Ashkenazi Jews. Am J Hum Genet 2003; 73: 246.
28. Klein WMP,. Self-prescriptive, perceived, and actual attention to comparative risk information. Psychol Health 2003; 18: 625-643.
29. Leventhal H, Benyamini Y, Brownlee S, et al,. Illness representations: theoretical foundations. In, KJ Petrie, JA Weinman, (Eds.), Perceptions of Health and Illness, 19-46. Harwood Academic Publishers: Australia, 1997.
30. Leventhal H, Leventhal EA, Contrada RJ,. Self regulation, health, and behavior: A perceptual-cognitive approach. Psychology & Health 1998; 13: 717-733.
31. Leventhal H, Brissette I, Leventhal EA,. The common-sense model of self-regulation of health and illness. In The Self-Regulation of Health and Illness Behaviour, Cameron LD, Leventhal H, (Eds.) 42-65. Routledge, 2003.
32. Leventhal H, Diefenbach MA, Leventhal EA,. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research 1992a; 16: 143-163.
33. Leventhal H, Leventhal EA, Contrada RJ,. Selfregulation, health, and behavior: a perceptual-cognitive approach. Psychol Health 1992b; 13: 717-733.
34. Liberman A, Chaiken S,. Defensive processing of personally relevant health messages. Personality and Social Psychology Bulletin 1992; 18: 669-679.
35. Liede A, Karlan BY, Narod SA,. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 2004; 22: 735-742.
36. Liede A, Metcalfe K, Hanna D, et al,. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 2000; 67: 1494-1504.
37. Lodder L, Frets PG, Trijsburg RW, et al,. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet 2001; 9: 492-500.
38. Lohan M,. How might we understand men's health better? Integrating explanations from critical studies on men and inequalities in health. Soc Sci Med 2007; 65: 493-504.
39. Lynch HT, Snyder C, Lynch JF, et al,. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006; 165: 91-97.
40. Mahalik JR, Burns SM, Syzdek M,. Masculinity and perceived normative health behaviors as predictors of men's health behaviors. Soc Sci Med 2007; 64: 2201-2209.
41. Marteau T,. Screening for carriers of cystic-fibrosis-psychological consequences are unclear. Br Med J 1994; 309: 1429-1430.
42. Marteau TM, Dundas R, Axworthy D,. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychol 1997; 16: 51-62.
43. Marteau TM, Weinman J,. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 2006; 62: 1360-1368.
44. McAllister MF, Evans DG, Ormiston W, Daly P,. Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet 1998; 35: 739-744.
45. Meiser B, Collins V, Warren R, et al,. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004; 66: 502-511.
46. Michie S, French DP, Marteau TM,. Predictive genetic testing: mediators and moderators of anxiety. Int J Behav Med 2002; 9: 309-321.
47. Mohamad HB, Apffelstaedt JP,. Counseling for male BRCA mutation carriers-a review. Breast 2008; 17: 441-450.
48. Moynihan C,. Men, women, gender and cancer. Eur J Cancer Care 2002; 11: 166-172.
49. O'Neill SC, Demarco T, Peshkin BN, et al,. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet C Semin Med Genet 2006; 142C: 251-259.
50. O'Neill SC, Rini C, Goldsmith RE, et al,. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psycho-Oncology 2009; 18: 1088-1096.
51. Ottini, L, Masala, G, D'Amico, C, et al,. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003; 63: 342-347.
52. Rees G, Fry A, Cull A, et al,. Illness perceptions and distress in women at increased risk of breast cancer. Psychol Health 2004; 19: 749-765.
53. Rini C, O'Neill SC, Valdimarsdottir H, et al,. Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results. Health Psychol 2009; 28: 569-578.
54. Shiloh S,. Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 2006; 15: 325-337.
55. Shiloh S, Drori E, Orr-Urtreger A, Friedman, E,. Being 'at-risk' for developing cancer: cognitive representations and psychological outcomes. J Behav Med 2009; 32: 197-208.
56. Smith KR, West JA, Croyle RT, Botkin JR,. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999; 8: 385-392.
57. Strømsvik N, Råheim M, Øyen N, Gjengedal E,. Men in the women's world of hereditary breast and ovarian cancer-a systematic review. Fam Cancer 2009; 8: 221-229.
58. Strømsvik N, Råheim M, Øyen N, Gjengedal E,. Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers. J Genet Couns 2010; 19: 360-370.
59. Stroup AM, Smith KR,. Familial effects of BRCA1 genetic mutation testing: changes in perceived family functioning. Cancer Epidemiol Biomarkers Prev 2007; 16: 135-141.
60. Tai YC, Domchek S, Parmigiani G, Chen S,. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99: 1811-1814.
61. Tercyak KP, Peshkin BN, Brogan BM, et al,. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 2007; 25: 285-291.
62. Thompson D, Easton D,. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001; 68: 410-419.
63. Thompson D, Easton DF,. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-1365.
64. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, et al,. The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study. Psycho-Oncology 2007; 16: 1121-1129.
65. Williams BG, Iredale R, Brain K, France E, Barrett-Lee P, Gray J,. Experiences of men with breast cancer: an exploratory focus group study. Br J Cancer 2003; 89: 1834-1836.